Corpus ID: 19196882

Medical Literature Imprinting by Pharma Ghost Writing: A Scientometric Evaluation

  title={Medical Literature Imprinting by Pharma Ghost Writing: A Scientometric Evaluation},
  author={P. Gorry},
  • P. Gorry
  • Published in ISSI 29 June 2015
  • Computer Science, Medicine
Introduction Misappropriation of authorship, honorary or ghost authorship, undermines academic publishing with a substantial proportion of peer-reviewed medical journals targeted (Flanagin, 1998). Pharmaceutical companies pay professional writers or medical communication companies to produce papers whilst paying other scientists or physicians to attach their names to these papers before they are published in medical or scientific journals. This ghost management is meant to support the marketing… 

Figures, Tables, and Topics from this paper

The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship
  • L. DeTora
  • Medicine
    International journal of clinical practice
  • 2016
Core texts in authorship and ghostwriting from the clinical literature and the 2010 Senate Minority Report on ghostwriting were reviewed as were uses of the term ‘ghostwriting’ in contemporary and more recent journalistic news coverage originally printed in English.
Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science
  • S. Sismondo
  • Medicine, Computer Science
    Frontiers in Research Metrics and Analytics
  • 2021
Much of the corruption of medical science via the pharmaceutical industry happens through grafting activities: Pharmaceutical companies do their own research and smoothly integrate it with medical science, taking advantage of the legitimacy of the latter.


Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.
A substantial proportion of articles in peer-reviewed medical journals demonstrate evidence of honorary authors or ghost authors.
Interface between authorship, industry and science in the domain of therapeutics
The emerging style of authorship in industry-linked articles can deliver good-quality articles, but it raises concerns for the scientific base of therapeutics, and the literature profiles and citation rates of industry- linked and non-industry- linked articles differ.
Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation
The findings suggest that Pfizer and Parke-Davis’s publication strategy for gabapentin had the potential to distort the scientific literature, and thus misinform healthcare decision-makers.
The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
Documents unsealed in recent litigation to investigate how pharmaceutical companies promoted hormone therapy drugs, including the use of medical writing companies to produce ghostwritten manuscripts and place them into medical journals are examined.
Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
Sismondo discusses how pharmaceutical companies and their agents shape multiple steps in the research, analysis, writing, and publication of articles.